Smoothing the path for intravenous (IV) to oral (PO) conversion: Where have we come in 11 years?

Hospital Pharmacy

Volumn 44, Issue 11, 2009, Pages 959-967

  Banko, Heidi ^a   Goldwater, Shannon H ^b   Adams, Erin ^c  

^a Inova Loudoun Hospital   (United States)

^b PFIZER INC   (United States)

^c SHENANDOAH UNIVERSITY   (United States)

Author keywords

Conversion; Cost savings; Intravenous; Oral

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; COTRIMOXAZOLE; DIURETIC AGENT; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; VORICONAZOLE;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL PHARMACY; COMPUTER; COST CONTROL; DEMOGRAPHY; E-MAIL; HEALTH CARE; HOSPITAL; HOSPITAL PLANNING; HOSPITAL POLICY; INTRAVENOUS DRUG ADMINISTRATION; MANAGER; MEDICAL SOCIETY; ORAL DRUG ADMINISTRATION; OUTCOME ASSESSMENT; PHARMACIST; PHYSICIAN; UNITED STATES;

EID: 75449110064     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4411-959     Document Type: Article

References (13)

1. Fischer MA, Solomon DH, Teich JM, Avorn J. Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized pa tients. Arch Intern Med. 2003;163:2585-2589.
2. Zamin MT, Pitre MM, Conly JM. Development of an intravenous-to-oral route conversion program for antimicrobial therapy at a Canadian tertiary care health facility. Ann Pharmacother. 1997; 31:564-1570.
3. Kuti JL, Le TN, Nightingale CH, Nicolau DP, Quintiliani R. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral. Am J Health Syst Pharm. 2002;59:2209-2215.
4. Glemaud I. Use of a physician order entry system to identify opportunities for intravenous to oral levofloxacin conversion. Am J Health Syst Pharm. 2000; 57(suppl 3):S14-S16.
5. Goldwater SH, Janifer AN, Milkovich, G, Chatelain F. Smoothing the path for i.v.-to-oral conversion. Am J Health Syst Pharm. 1997;54:200, 205.
6. Hunter KA, Dormaier GK. Pharmacist-managed intravenous to oral stepdown program. Clinical Ther. 1995;17: 3:534-540.
7. Fox ER, Beckwith MC, Tyler LS. Pharmacy-administered IV to oral therapeutic interchange program: development, implementation, and cost-assessment. Hosp Pharm. 2003;38:444-452, 462.
8. Laing RB, Mackenzie AR, Shaw H, Gould IM, Douglas JG. The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards. J Antimicrob Chemother. 1998;42: 107-111.
9. Sevinc F, Prins J, Koopmans RP, et al. Early switch form intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrobial Chemotherapy. 1999; 43:601-606.
10. Wong-Beringer A, Nguyen KH, Razeghi J. Implementing a program for switching from i.v. to oral antimicrobial therapy. Am J Health Syst Pharm. 2001; 58:1146-1149.
11. Finley R. Survey Monkey.com. Portland, OR. http://www.surveymonkey .com. Accessed September 10, 2007.
12. National Hospital Discharge Survey: 2004 Annual Summary with Detailed Diagnosis and Procedure Data. Vital and Health Statistics. 2006; Series 13, No 162. http://www.cdc.gov/nchs/data. Accessed November 19, 2007.
13. CDC. National Center for Health Statistics. Hospital Utilization (in Non-Federal Short-Stay Hospitals) http://www .cdc.gov/nchs/fastats/hospital.htm. Accessed November 18, 2007.